Does GRK2 inhibition with βARKct reduce acute ischemic myocardial injury?
GRK2 inhibition with βARKct demonstrates therapeutic potential for reducing acute ischemic myocardial injury through mechanisms involving increased Akt activity and NO production.
The novel effect of reducing acute ischemic myocardial injury via increased Akt activity and NO production adds significantly to the therapeutic potential of GRK2 inhibition with the βARKct not only in chronic HF but also potentially in acute ischemic injury conditions.
Brinks et al. (Fri,) studied this question.